The Neuroscience and Neoplasia Artificial Intelligence Research Group (NAIRG) is dedicated to pioneering research at the intersection of neuroscience, cancer, and artificial intelligence (AI). Our work focuses on leveraging AI to enhance the understanding, diagnosis, and management of neurodegenerative diseases, neuropsychiatric disorders, and cancers such as lung cancer and lymphoma. By integrating advanced AI techniques like radiomics, machine learning, and explainable AI, we aim to identify biomarkers, predict disease prognosis, and improve treatment strategies. At NAIRG, we are committed to driving innovation and transforming healthcare through cutting-edge research.